Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

SYNERGEN LEADS BIOTECH STOCK SLIDE

Sep. 24, 1991

GENENTECH TO CO-DEVELOP SEPSIS DRUG

Sep. 24, 1991

MONTGOMERY SECURITIES CONFERENCE

Sep. 24, 1991

SHAMAN GETS APPROVAL TO TEST ANTI-VIRAL

Sep. 24, 1991

SALE OF CETUS' PCR PASSES HURDLE

Sep. 24, 1991

GENPHARM GETS RIGHTS TO TRANSGENIC MICE

Sep. 24, 1991

PREMIUM FOR GI IS NO BLOCKBUSTER

Sep. 23, 1991

BTGC GROWTH HORMONE APPROVED

Sep. 23, 1991

APPOINTMENTS AND ADVANCEMENTS

Sep. 23, 1991

MICROPROBE GRANT FOR ANTIGENE TECHNOLOGY

Sep. 23, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...